NDC11 00003712511
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00003-7125-11 | 00003-7125 |
| 0003-7125-11 | 0003-7125 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OPDUALAG | NIVOLUMAB AND RELATLIMAB-RMBW | E.R. Squibb & Sons, L.L.C. | b22c9d83-3256-4e17-85f7-f331a504adc6 | 2026-06-08 | Warnings, Adverse reactions | 0003-7125-11 0003-7125 00003712511 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.